SCHEMBL6491001

SCHEMBL6491001

COC(=O)c1ncccc1Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.51
PKM P14618 1/20 0.50
HSP90AA1 P07900 2/20 0.49
RNASEH1 O60930 1/20 0.48
CYP1A2 P05177 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
MAPT P10636 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
CYP2C19 P33261 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
HIF1A Q16665 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HRH1 P35367 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8117183 0.84 BRD4 (0.52) L3MBTL1MAPTALDH1A1TSHRSMN1; SMN2
SCHEMBL28117989 0.84 PARP1 (0.47) PARP1L3MBTL1HSP90AA1MAPTALDH1A1
SCHEMBL163384 0.82 KDM4E (0.50) L3MBTL1CYP1A2MAPTALDH1A1CYP3A4
SCHEMBL535668 0.82 L3MBTL1 (0.58) PARP1L3MBTL1PKMCYP1A2TDP1
SCHEMBL2960936 0.82 KDM4E (0.64) L3MBTL1RNASEH1CYP1A2MAPTALDH1A1
SCHEMBL29556499 0.81 KDM4E (0.68) PARP1L3MBTL1PKMCYP1A2TDP1
SCHEMBL21678221 0.81 L3MBTL1 (0.54) PARP1L3MBTL1PKMCYP1A2TDP1
SCHEMBL1551666 0.81 KDM4E (0.46) L3MBTL1CYP1A2MAPTALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL8126278 0.81 KDM4E (0.62) L3MBTL1RNASEH1CYP1A2MAPTALDH1A1
SCHEMBL28677368 0.81 L3MBTL1 (0.57) PARP1L3MBTL1PKMCYP1A2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors ZHUANG LINGHANG (US) 2005-01-13 US disclosed
EP-1333831-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-08-13 EP disclosed
WO-2002036734-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors POLI, CYP51A1, DUT PARP1 98/4885L3MBTL1 1960/4885PKM 1059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.